Skip to content
Screener

Precigen PGEN Shares (Diluted)

Shares (Diluted) at other companies

Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
106M-2.4%
Gilead Sciences logo
Gilead SciencesGILD
1.2B-1.0%
Allogene Therapeutics logo
Allogene TherapeuticsALLO
240.3M+11.6%
Apogee Therapeutics, Inc. logo
Apogee Therapeutics, Inc.APGE
69.7M+19.7%
Regenxbio logo
RegenxbioRGNX
53M+3.0%
Opko Health logo
Opko HealthOPK
755.3M-4.2%

Other financials

Income statement

See full
Revenue$23.3M+1,634%
Operating income-$6.0M+73.5%
Net income-$7.9M+85.4%
EPS (diluted)-$0.02+88.9%

Balance sheet

See full
Cash & equivalents$7.5M+23.5%
Total debt$98.3M+1,714%
Total equity$20.2M+244%
Total assets$138.6M+7.6%

Cash flow

See full
Operating cash flow-$43.8M-168%
CapEx$258.0K-58.5%
Free cash flow-$44.1M-160%

Valuation

See full
Market cap$2.59B+404%
Enterprise value$2.68B+431%
P/S97.5×

Profitability

See full
Gross margin83.6%
Operating margin-2,890.9%
Net margin-3,656%
FCF margin-1,756.5%

Returns & leverage

See full
Return on equity-843.6%-1,103pp
Debt / equity4.9×
Current ratio4.8×+1.3×

Where this comes from

Reported directly by Precigen in its filing.

Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding.

The source filing: Precigen’s 10-Q, filed May 13, 2026.

Filed
May 13, 2026, 4:20 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001356090-26-000017
(Amounts in thousands, except share and per share data)Three Months Ended March 31, 2026Three Months Ended March 31, 2025
Other income, net2907
Total other income (expense), net(1,935)(31,557)
Loss before income taxes(7,929)(54,153)
Income tax expense
Net loss$(7,929)$(54,153)
Net loss per share
Net loss per share, basic and diluted$(0.02)$(0.18)
Weighted average shares outstanding, basic and diluted354,291,007293,879,653

Item 1. Condensed Consolidated Financial Statements

FAQ

What is Precigen's shares (diluted)?
Precigen (PGEN) reported shares (diluted) of 354.3M in Q1 2026.
How has Precigen's shares (diluted) changed year-over-year?
Precigen's shares (diluted) increased by 20.6% year-over-year, from 293.9M to 354.3M.
What is the long-term trend for Precigen's shares (diluted)?
Over 4 years (2021 to 2025), Precigen's shares (diluted) has grown at a 11.3% compound annual growth rate (CAGR), from 789.5M to 1.2B.
What does shares (diluted) mean?
The weighted-average shares outstanding plus all potentially dilutive shares from stock options, RSUs, convertible securities, and warrants, using the treasury stock method.

Ask your AI about Precigen's shares (diluted).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude